Pharmacologic Treatment of Tic Disorders-Reference-Cited by-同舟云学术

Pharmacologic Treatment of Tic Disorders

Published:2000-01 Issue:1 Volume:9 Page:99-117
ISSN:1056-4993
Container-title:Child and Adolescent Psychiatric Clinics of North America
language:en
Short-container-title:Child and Adolescent Psychiatric Clinics of North America

Author:

Scahill Lawrence,Chappell Phillip B.,King Robert A.,Leckman James F.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Reference103 articles.

1. Diagnostic and Statistical Manual,1994

2. The contribution of cx2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance of attention-deficit hyperactivity disorder;Arnsten;Arch Gen Psychiatry,1996

3. Clonazepam treatment of obsessive compulsive disorder [letter];Bacher;J Clin Psychiatry,1990

4. Guanfacine as an cx2-agonist inducer of growth hormone secretion-a comparison with clonidine;Balldin;Psychoneuroendocrinology,1993

5. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic, placebo-controlled evaluation;Barkley;Pediatrics,1992

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychopharmacology Management in Autism Spectrum Disorder;Pediatric Clinics of North America;2024-04

2. Tics;Medical Management of Psychotropic Side Effects;2017

3. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment;European Child & Adolescent Psychiatry;2011-03-29

4. Otras aplicaciones de la toxina botulínica;Toxina Botulínica;2010

5. Reduced platelet vesicular monoamine transporter density in Tourette's syndrome pediatric male patients;European Neuropsychopharmacology;2007-07